CHCL-B.NE
CI Global Healthcare Leaders Index ETF
Cboe CACADETF / FUND
DELAYED
Last price
26.91
▲ 0.18 (0.67%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
26.73
Day high
26.91
Day low
26.91
Volume
1
Market cap
—
P/E (TTM)
27.76
52W range
21.61 – 26.91
Trailing performance
Returnvs SPY
1W
+1.60%
+3.0%
1M
+4.41%
+0.7%
3M
+14.38%
+11.3%
6M
+6.88%
-4.2%
YTD
+8.97%
-3.3%
1Y
+21.72%
+1.7%
3Y
+27.16%
-47.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Top holdings
| Symbol | Name | Weight | |
|---|---|---|---|
| LLY | Eli Lilly and Co | 11.22% | |
| JNJ | Johnson & Johnson | 7.14% | |
| ABBV | AbbVie Inc | 5.16% | |
| UNH | UnitedHealth Group Inc | 4.34% | |
| MRK | Merck & Co Inc | 3.72% | |
| ROP.SW | Roche Holding AG Ordinary Shares new | 3.55% | |
| NOVN.SW | Novartis AG Registered Shares | 3.28% | |
| AZN.L | AstraZeneca PLC | 2.95% | |
| TMO | Thermo Fisher Scientific Inc | 2.46% | |
| AMGN | Amgen Inc | 2.39% |
Sector exposure
Healthcare
99.61%
Industrials
0.32%
Technology
0.07%
Fund profile
Fund familyCI Investments Inc
Category—
Legal typeExchange Traded Fund
Expense ratio0.00%
Turnover18.6%
Total net assets$212.81M
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CHCL-B.NE open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E27.76
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
26.33
+2.20% from price
SMA 20
26.17
+2.15% from price
SMA 50
25.67
+4.11% from price
SMA 100
24.59
+9.42% from price
SMA 200
24.53
+8.97% from price
EMA 12
26.29
+2.36% from price
EMA 26
26.05
+3.28% from price
EMA 50
25.63
+4.98% from price
RSI (14)
67.3
Neutral
MACD (12,26,9)
0.23
Hist 0.01
ATR (14)
0.14
0.54% of price
Realised vol 30D
14.9%
Annualised
Bollinger upper
26.72
20, 2σ
Bollinger lower
25.61
20, 2σ
50 / 200 cross
Golden
25.67 vs 24.53
Trend bias
Above 200
+8.97%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.16
Less volatile than market
Correlation to SPY
0.14
Largely independent
Realised vol 30D
14.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-10.9%
Peak to trough
Max drawdown 5Y
-16.4%
Peak to trough
ATR 14
0.14
0.54% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Dow Jones Futures Fall With Market At Key Point; Nvidia, Tariffs, Warsh In Focus
Investor's Business Daily · 9m ago
Danaher vs. Medtronic: Which Healthcare Recovery Story Has More Upside?
Insider Monkey · 10m ago
Liga holders Barcelona crush Elche, Atletico salvage Villarreal draw
AFP · 12m ago
Micron CEO is doubling down on a cycle-free future
TheStreet · 14m ago
U.S. Steel Stocks Nucor, Steel Dynamics: Big Winners As Canada Trade Talks Collapse?
Investor's Business Daily · 19m ago
AI Firm Exposes Ledger Bug, CTO Calls It Fear-Mongering After Quiet Fix
BeInCrypto · 21m ago
The Apex Institute Explains Why Skilled Engineers Still Fail Technical Interviews
PR Newswire · 21m ago
Tesla Maintained Its Majority of the U.S. EV Market in Q2, but That's Not All You Need to Know
Motley Fool · 25m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.